MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
Published March 11, 2026 · Recall initiated: December 15, 2025
Summary
FDA records drug Class I recall D-0397-2026, published March 11, 2026 and initiated December 15, 2025. Recalling firm: StuffbyNainax; Status: Ongoing; Reported quantity: 4; Lot: All codes; Exp 12/31/2029. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- StuffbyNainax
- Distributor
- Product was distributed to 4 customers in the US.
- Lot
- All codes; Exp 12/31/2029
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc.March 11, 2026
- FDAAmnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only,March 11, 2026
- FDATirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe,March 11, 2026
- FDAPremium Food Jordan Almonds, packed in 2.0 oz and 3.5 oz clear flexible plastic packaging.March 11, 2026
- FDATirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KSMarch 11, 2026
- FDAPremium Food Bubble Gum, packed in 2.5 oz clear flexible plastic packaging, all lots and codes. Sold in unitMarch 11, 2026
Questions about this recall
Was MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7 recalled?
Yes. FDA published recall D-0397-2026 on March 11, 2026. Reported hazard: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
What should I do if I have this product?
Voluntary: Firm initiated · Press Release